Pharmacogenomics Global Market Opportunities And Strategies To 2032

Pharmacogenomics Market 2023 – By Technology (Next Generation Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, Other Technologies), By Application (Neurological Diseases, Infectious Diseases, Oncology, Cardiovascular Diseases, Pain Management, Other Applications), By End User (Hospitals and Clinics, Research Institutions, Academic Institutes, Other End Users), And By Region, Opportunities And Strategies – Global Forecast To 2032

Starting Price : $5000.00 | Pages : 297 | Published : December 2023 | | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN

Pharmacogenomics Market Definition

Pharmacogenomics is a field of research that studies how a person's genes affect how they respond to medications. It combines pharmacology, the science of drugs and genomics, the study of genes and their functions, to develop effective and safe medications that can be prescribed based on a person's genetic makeup.  

The pharmacogenomics market consists of sales of services related to pharmacogenomics by entities (organizations, sole traders and partnerships) that use pharmacogenomic testing to determine the best medication for a patient. Knowing how a person's DNA (deoxyribonucleic acid) affects the way they respond to drugs can help doctors find medicine that will work best for them.

Pharmacogenomics Market Size

The global pharmacogenomics market reached a value of nearly $7,325.7 million in 2022, having grown at a compound annual growth rate (CAGR) of 7.7% since 2017. The market is expected to grow from $7,325.7 million in 2022 to $11,558.5 million in 2027 at a rate of 9.5%. The market is then expected to grow at a CAGR of 12.2% from 2027 and reach $20,522.2 million in 2032.    

Growth in the historic period resulted from strong economic growth in emerging markets, the increasing focus on personalized medicine, the rising advanced healthcare infrastructure and increased healthcare expenditure. Factors that negatively affected growth in the historic period were low healthcare access in developing countries and high costs associated with treatment based on pharmacogenomics.

Going forward, the increasing aging population, the increasing chronic diseases, the rising population and the increasing demand for cancer treatment will drive the market. Factors that could hinder the growth of the pharmacogenomics market in the future include a lack of skilled workers and regulatory challenges.

Pharmacogenomics Market Drivers

The key drivers of the pharmacogenomics market include:

Increasing Aging Population

An increase in the size of the aging population is expected to drive the growth of the pharmacogenomics market going forward. Aging can lead to changes in the body's ability to metabolize and respond to drugs. Pharmacogenomic testing can identify genetic variations that affect drug metabolism, allowing healthcare providers to tailor medication regimens to the specific needs of elderly patients. This customization can enhance drug safety and efficacy in older individuals. For example, in October 2022, according to the World Health Organization, by 2030, 1 in 6 people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world’s population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. Additionally, in August 2021, according to the National Statistical Office, an India-based autonomous body, India’s elderly population (aged 60 and above) is projected to touch 194 million in 2031 from 138 million in 2021, a 41% increase over a decade. Therefore, the aging population is expected to drive the demand for the pharmacogenomics market during the forecast period.

Pharmacogenomics Market Restraints

The key restraints on the pharmacogenomics market include:

Lack Of Skilled Workers

The lack of skilled workers in pharmacogenomics will contribute to a shortage of services during the forecast period. Pharmacogenomics involves the analysis of vast amounts of genetic and clinical data. Skilled professionals, such as bioinformaticians, geneticists and data scientists, are needed to interpret this data accurately. A shortage of skilled workers in these fields can hinder the effective utilization of pharmacogenomic information. For example, in April 2022, according to Pharmaceutical Journals, a London-based professional journal covering various aspects of pharmacy, including pharmacology and pharmaceutics, training for pharmacy personnel across various healthcare sectors is currently inadequate. While pharmacy staff may not require expertise in genomics, they must possess a sufficient level of knowledge and comprehension to effectively perform their daily duties, which will be influenced by pharmacogenomics. Therefore, the lack of skilled workers will negatively impact the growth of the pharmacogenomics market.

Pharmacogenomics Market Trends

Major trends influencing the pharmacogenomics market include:

Launch Of Genome Editing Solution For Deeper Analysis Of Advanced Therapies

The launch of genome editing solution for deeper analysis of advanced therapies is the latest trend gaining popularity in the pharmacogenomics market. Genome editing is a powerful tool in advancing research and development in the field of advanced therapies. These therapies include gene therapy, cell therapy and regenerative medicine, which aim to treat various diseases by modifying or replacing genetic material, cells, or tissues. Genome editing technologies enable precise and targeted modifications to the genome, enhancing the ability to understand, develop and improve advanced therapies. For example, in September 2023, Mission Bio, a US-based life sciences company that focuses on single-cell DNA and multi-omics analysis, launched the Tapestri Genome Editing Solution. This new solution addresses a long-standing gap in advanced therapy development, disease modeling and functional genomics by providing high-resolution analysis of genome editing. The Tapestri Genome Editing Solution allows for the rapid characterization of gene-edited drug products, identifying on- and off-target editing, the zygosity of edits and the co-editing of multiple targets in single cells. The solution also supports multi-omics analysis, co-measuring editing and cell-surface protein expression in the same cells.

Focus On Integration Of Artificial Intelligence (AI) In Genomics To Analyze Genetic Data

Companies in the market are focusing on integration of artificial intelligence (AI) in genomics to analyze genetic data. AI-driven genomics could be used to identify and target the underlying causes of diseases to prevent them from occurring. AI-driven functional genomics is expected to continue to grow in the future.  For example, in June 2023, Illumina, a US-based developer and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function, developed PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts disease-causing genetic mutations in patients with unprecedented accuracy. PrimateAI-3D uses deep neural network architectures like ChatGPT and AlphaFold, but unlike these models, which are trained on human language, PrimateAI-3D is trained on genome sequences. The genetic variants that cause disease in the human genome are largely unknown, which presents a challenge for training the algorithm. To overcome this, PrimateAI-3D uses natural selection to train the parameters of the deep neural network, using millions of benign genetic variants identified through the sequencing of 233 diverse primate species. The algorithm has also greatly improved the accuracy of genetic risk prediction, enabling the first demonstration of polygenic risk scores that were largely unaffected by ancestry bias.

Opportunities And Recommendations In The Pharmacogenomics Market

Opportunities –The top opportunities in the pharmacogenomics market segmented by technology will arise in the polymerase chain reaction segment, which will gain $1,756.5 million of global annual sales by 2027. The top opportunities in the pharmacogenomics market segmented by application will arise in the oncology segment, which will gain $1,950.4 million of global annual sales by 2027. The top opportunities in the pharmacogenomics market segmented by end user will arise in the hospitals and clinics segment, which will gain $1,679.7 million of global annual sales by 2027. The pharmacogenomics market size will gain the most in the USA at $1,613.8 million.

Recommendations-To take advantage of the opportunities, the business research company recommends the pharmacogenomics companies to focus on launch of genome editing solutions for deeper analysis of advanced therapies, focus on integration of artificial intelligence (AI) in genomics, focus on growing advancements in metagenomics, focus on introduction of three-dimensional (3D) genomics, focus on new product innovations for infectious diseases and gene editing, focus on development of psychotropic pharmacogenomics test, expand in emerging markets, continue to focus on developed markets, focus on strategic partnerships and collaborations, provide competitively priced offerings, participate in trade shows and events, continue to use B2B promotions, continue to target fast-growing applications and focus on fast-growing end-users.

Pharmacogenomics Market Segmentation

The pharmacogenomics market is segmented by technology, by application and by end user.
By Technology –
The pharmacogenomics market is segmented by technology into:
    • a) Next Generation Sequencing
    • b) Polymerase Chain Reaction
    • c) Gel Electrophoresis
    • d) Mass Spectrometry
    • e) Microarray
    • f) Other Technologies
The polymerase chain reaction market was the largest segment of the pharmacogenomics market segmented by technology, accounting for 39.9% or $2,920.1 million of the total in 2022. Going forward, the next generation sequencing segment is expected to be the fastest growing segment in the pharmacogenomics market segmented by technology, at a CAGR of 10.7% during 2022-2027.
By Application –
The pharmacogenomics market is segmented by application into:
    • a) Neurological Diseases
    • b) Infectious Diseases
    • c) Oncology
    • d) Cardiovascular Diseases
    • e) Pain Management
    • f) Other Applications
The oncology market was the largest segment of the pharmacogenomics market segmented by application, accounting for 41.0% or $3,005.2 million of the total in 2022. Going forward, the oncology segment is expected to be the fastest growing segment in the pharmacogenomics market segmented by application, at a CAGR of 10.5% during 2022-2027.
By End User –
The pharmacogenomics market is segmented by end user into:
    • a) Hospitals And Clinics
    • b) Research Institutions
    • c) Academic Institutes
    • d) Other End Users
The hospitals and clinics market was the largest segment of the pharmacogenomics market segmented by end user, accounting for 39.1% or $2,860.9 million of the total in 2022. Going forward, the research institutions segment is expected to be the fastest growing segment in the pharmacogenomics market segmented by end user, at a CAGR of 10.2% during 2022-2027.
By Geography - The pharmacogenomics market is segmented by geography into:
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the pharmacogenomics market, accounting for 42.2% or $3,094.3 million of the total in 2022. It was followed by Western Europe, Asia-Pacific and then the other regions. Going forward, the fastest-growing regions in the pharmacogenomics market will be Asia-Pacific and Western Europe, where growth will be at CAGRs of 12.4% and 9.8% respectively. These will be followed by North America and South America, where the markets are expected to grow at CAGRs of 8.9% and 8.3% respectively.

Pharmacogenomics Market Competitive Landscape

Major Competitors are:

  • Illumina Inc.
  • Eurofins Scientific
  • Myriad Genetics Inc
  • PerkinElmer Inc.
  • Centogene N.V
  • Other Competitors Include:

  • Invitae Corporation
  • Genomind
  • Pacific Biosciences of California Inc.
  • Oneome LLC
  • Admera Health
  • MapMyGenome
  • Positive Bioscience
  • Xcode Life Sciences
  • Xcelris Labs
  • Takeda Pharmaceutical Company Limited
  • Garvan Institute of Medical Research
  • 3D Medicines Inc
  • Berry Genomics
  • BGI
  • GenomiCare Biotechnology
  • Biotecan Pharmaceuticals
  • Bayer AG
  • GlaxoSmithKline plc (GSK)
  • F Hoffmann-La Roche AG
  • Merck KGaA
  • Future Science Group
  • QIAGEN N.V
  • Institute of Biomedical Chemistry
  • Centro de Genoma e Biologia de Sistemas (CGBS)
  • Dasa Group
  • Datar Cancer Genetics Limited
  • MedGenome Labs
  • AnorMed
  • 23andMe
  • Myriad Genetics
  • Color Genomics
  • Pathway Genomics
  • Laboratório Richet
  • Laboratório Exame
  • Genomika Diagnósticos
  • Gulf Pharmaceutical Industries JULPHA
  • Neopharm
  • NewBridge Pharmaceuticals Limited
  • EIPICO (Egyptian International Pharmaceutical Industries Company)
  • Aspen Pharmacare Holdings Limited
  • Pharma-Q (Pty) Ltd
    1. Table Of Contents

      1. Executive Summary

      2. Table Of Contents

      3. List Of Figures

      4. List Of Tables

      5. Report Structure

      6. Introduction And Market Characteristics

      6.1. General Market Definition

      6.2. Summary

      6.3. Pharmacogenomics Market Definition And Segmentations

      6.4. Market Segmentation By Technology

      6.4.1. Next Generation Sequencing

      6.4.2. Polymerase Chain Reaction

      6.4.3. Gel Electrophoresis

      6.4.4. Mass Spectrometry

      6.4.5. Microarray

      6.4.6. Other Technologies

      6.5. Market Segmentation By Application

      6.5.1. Neurological Diseases

      6.5.2. Infectious Diseases

      6.5.3. Oncology

      6.5.4. Cardiovascular Diseases

      6.5.5. Pain Management

      6.5.6. Other Applications

      6.6. Market Segmentation By End User

      6.6.1. Hospitals And Clinics

      6.6.2. Research Institutions

      6.6.3. Academic Institutes

      6.6.4. Other End Users

      7. Major Market Trends

      7.1. Launch Of Genome Editing Solution For Deeper Analysis Of Advanced Therapies

      7.2. Focus On Integration Of Artificial Intelligence (AI) In Genomics To Analyze Genetic Data

      7.3. Growing Advancements In Metagenomics

      7.4. Strategic Partnerships And Collaborations Among Market Players

      7.5. Introduction Of Three-Dimensional (3D) Genomics To Study Influences On Gene Expression And Function

      7.6. New Product Innovations With Focus On Infectious Diseases And Gene Editing

      7.7. Development Of Psychotropic Pharmacogenomics Test For Informed Decisions

      8. Pharmacogenomics Market – Macro-Economic Scenario

      8.1. COVID-19 Impact On The Pharmacogenomics Market

      8.2. Impact Of The War In Ukraine On The Pharmacogenomics Market

      8.3. Impact Of High Inflation On The Pharmacogenomics Market

      9. Global Market Size and Growth

      9.1. Market Size

      9.2. Historic Market Growth, 2017 – 2022, Value ($ Million)

      9.2.1. Market Drivers 2017 – 2022

      9.2.2. Market Restraints 2017 – 2022

      9.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      9.3.1. Market Drivers 2022 – 2027

      9.3.2. Market Restraints 2022 – 2027

      10. Global Pharmacogenomics Market Segmentation

      10.1. Global Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      10.2. Global Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      10.3. Global Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11. Pharmacogenomics Market, Regional and Country Analysis

      11.1. Global Pharmacogenomics Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.2. Global Pharmacogenomics Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12. Asia-Pacific Market

      12.1. Summary

      12.2. Market Overview

      12.2.1. Region Information

      12.2.2. Market Information

      12.2.3. Background Information

      12.2.4. Government Initiatives

      12.2.5. Regulations

      12.2.6. Regulatory Bodies

      12.2.7. Major Associations

      12.2.8. Taxes Levied

      12.2.9. Corporate Tax Structure

      12.2.10. Investments

      12.2.11. Major Companies

      12.3. Asia-Pacific Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      12.4. Asia-Pacific Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      12.5. Asia-Pacific Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.6. Asia-Pacific Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.7. Asia-Pacific Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.8. Asia-Pacific Pharmacogenomics Market: Country Analysis

      12.9. China Market

      12.10. Summary

      12.11. Market Overview

      12.11.1. Country Information

      12.11.2. Market Information

      12.11.3. Background Information

      12.11.4. Government Initiatives

      12.11.5. Regulations

      12.11.6. Regulatory Bodies

      12.11.7. Major Associations

      12.11.8. Taxes Levied

      12.11.9. Corporate Tax Structure

      12.11.10. Investments

      12.11.11. Major Companies

      12.12. China Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      12.13. China Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      12.14. China Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.15. China Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.16. China Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.17. India Market

      12.18. India Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      12.19. India Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      12.20. India Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.21. India Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.22. India Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.23. Japan Market

      12.24. Japan Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      12.25. Japan Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      12.26. Japan Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.27. Japan Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.28. Japan Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.29. Australia Market

      12.30. Australia Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      12.31. Australia Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      12.32. Australia Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.33. Australia Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.34. Australia Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.35. Indonesia Market

      12.36. Indonesia Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      12.37. Indonesia Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      12.38. Indonesia Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.39. Indonesia Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.40. Indonesia Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.41. South Korea Market

      12.42. South Korea Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      12.43. South Korea Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      12.44. South Korea Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.45. South Korea Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.46. South Korea Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13. Western Europe Market

      13.1. Summary

      13.2. Market Overview

      13.2.1. Region Information

      13.2.2. Market Information

      13.2.3. Background Information

      13.2.4. Government Initiatives

      13.2.5. Regulations

      13.2.6. Regulatory Bodies

      13.2.7. Major Associations

      13.2.8. Taxes Levied

      13.2.9. Corporate Tax Structure

      13.2.10. Investments

      13.2.11. Major Companies

      13.3. Western Europe Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      13.4. Western Europe Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      13.5. Western Europe Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.6. Western Europe Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.7. Western Europe Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.8. Western Europe Pharmacogenomics Market: Country Analysis

      13.9. UK Market

      13.10. UK Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      13.11. UK Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      13.12. UK Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.13. UK Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.14. UK Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.15. Germany Market

      13.16. Germany Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      13.17. Germany Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      13.18. Germany Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.19. Germany Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.20. Germany Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.21. France Market

      13.22. France Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      13.23. France Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      13.24. France Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.25. France Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.26. France Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14. Eastern Europe Market

      14.1. Summary

      14.2. Market Overview

      14.2.1. Region Information

      14.2.2. Market Information

      14.2.3. Background Information

      14.2.4. Government Initiatives

      14.2.5. Regulations

      14.2.6. Regulatory Bodies

      14.2.7. Major Associations

      14.2.8. Taxes Levied

      14.2.9. Corporate Tax Structure

      14.2.10. Investment

      14.2.11. Major Companies

      14.3. Eastern Europe Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      14.4. Eastern Europe Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      14.5. Eastern Europe Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14.6. Eastern Europe Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14.7. Eastern Europe Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14.8. Eastern Europe Pharmacogenomics Market: Country Analysis

      14.9. Russia Market

      14.10. Russia Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      14.11. Russia Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      14.12. Russia Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14.13. Russia Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14.14. Russia Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15. North America Market

      15.1. Summary

      15.2. Market Overview

      15.2.1. Region Information

      15.2.2. Market Information

      15.2.3. Background Information

      15.2.4. Government Initiatives

      15.2.5. Regulations

      15.2.6. Regulatory Bodies

      15.2.7. Major Associations

      15.2.8. Taxes Levied

      15.2.9. Corporate Tax Structure

      15.2.10. Investments

      15.2.11. Major Companies

      15.3. North America Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      15.4. North America Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      15.5. North America Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15.6. North America Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15.7. North America Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15.8. North America Pharmacogenomics Market: Country Analysis

      15.9. USA Market

      15.10. Summary

      15.11. Market Overview

      15.11.1. Country Information

      15.11.2. Market Information

      15.11.3. Background Information

      15.11.4. Government Initiatives

      15.11.5. Regulations

      15.11.6. Regulatory Bodies

      15.11.7. Major Associations

      15.11.8. Taxes Levied

      15.11.9. Corporate Tax Structure

      15.11.10. Investments

      15.11.11. Major Companies

      15.12. USA Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      15.13. USA Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      15.14. USA Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15.15. USA Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15.16. USA Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      16. South America Market

      16.1. Summary

      16.2. Market Overview

      16.2.1. Region Information

      16.2.2. Market Information

      16.2.3. Background Information

      16.2.4. Government Initiatives

      16.2.5. Regulations

      16.2.6. Regulatory Bodies

      16.2.7. Major Associations

      16.2.8. Taxes Levied

      16.2.9. Corporate Tax Structure

      16.2.10. Investments

      16.2.11. Major Companies

      16.3. South America Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      16.4. South America Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      16.5. South America Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      16.6. South America Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      16.7. South America Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      16.8. South America Pharmacogenomics Market: Country Analysis

      16.9. Brazil Market

      16.10. Brazil Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      16.11. Brazil Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      16.12. Brazil Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      16.13. Brazil Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      16.14. Brazil Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      17. Middle East Market

      17.1. Summary

      17.2. Market Overview

      17.2.1. Region Information

      17.2.2. Market Information

      17.2.3. Background Information

      17.2.4. Government Initiatives

      17.2.5. Regulations

      17.2.6. Regulatory Bodies

      17.2.7. Major Associations

      17.2.8. Taxes Levied

      17.2.9. Corporate Tax Structure

      17.2.10. Investments

      17.2.11. Major Companies

      17.3. Middle East Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      17.4. Middle East Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      17.5. Middle East Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      17.6. Middle East Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      17.7. Middle East Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      18. Africa Market

      18.1. Summary

      18.2. Market Overview

      18.2.1. Region Information

      18.2.2. Market Information

      18.2.3. Background Information

      18.2.4. Government Initiatives

      18.2.5. Regulations

      18.2.6. Regulatory Bodies

      18.2.7. Major Associations

      18.2.8. Taxes Levied

      18.2.9. Corporate Tax Structure

      18.2.10. Investments

      18.2.11. Major Companies

      18.3. Africa Pharmacogenomics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      18.4. Africa Pharmacogenomics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      18.5. Africa Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      18.6. Africa Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      18.7. Africa Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      19. Competitive Landscape And Company Profiles

      19.1. Company Profiles

      19.2. Illumina Inc

      19.2.1. Company Overview

      19.2.2. Products And Services

      19.2.3. Business Strategy

      19.2.4. Financial Overview

      19.3. Eurofins Scientific SE

      19.3.1. Company Overview

      19.3.2. Products And Services

      19.3.3. Business Strategy

      19.3.4. Financial Overview

      19.4. Myriad Genetics Inc

      19.4.1. Company Overview

      19.4.2. Products And Services

      19.4.3. Business Strategy

      19.4.4. Financial Overview

      19.5. PerkinElmer Inc

      19.5.1. Company Overview

      19.5.2. Products And Services

      19.5.3. Business Strategy

      19.5.4. Financial Overview

      19.6. Centogene N.V

      19.6.1. Company Overview

      19.6.2. Products And Services

      19.6.3. Business Strategy

      19.6.4. Financial Overview

      20. Key Mergers And Acquisitions

      20.1. Genomenon, Inc Acquired Boston Genetics

      20.2. Incite Health PTY Limited Acquired CNSDose

      20.3. Moderna Acquired OriCiro Genomics

      20.4. RetinalGenix Technologies Acquired DNA/GPS

      20.5. Castle Biosciences, Inc Acquired AltheaDx

      20.6. LetsGetChecked Announced Acquisition Of Veritas Genetics And Veritas Intercontinental

      20.7. Element Biosciences Acquired Loop Genomics

      20.8. Invitae Corporation Acquired YouScript, Inc And Genelex

      21. Opportunities And Strategies

      21.1. Global Pharmacogenomics Market In 2027 – Countries Offering Most New Opportunities

      21.2. Global Pharmacogenomics Market In 2027 – Segments Offering Most New Opportunities

      21.3. Global Pharmacogenomics Market In 2027 – Growth Strategies

      21.3.1. Market Trend Based Strategies

      21.3.2. Competitor Strategies

      22. Pharmacogenomics Market, Conclusions And Recommendations

      22.1. Conclusions

      22.2. Recommendations

      22.2.1. Product

      22.2.2. Place

      22.2.3. Price

      22.2.4. Promotion

      22.2.5. People

      23. Appendix

      23.1. Market Data Sources

      23.2. Research Methodology

      23.3. Currencies

      23.4. The Business Research Company

      23.5. Copyright and Disclaimer

    List Of Tables

      Table 1: Global Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Table 2: Global Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 3: Global Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 4: Global Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 5: Global Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 6: Global Pharmacogenomics Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 7: Global Pharmacogenomics Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 8: Asia-Pacific GDP Per Capita, By Country, 2017-2022, $
    • Table 9:  Asia-Pacific Population, By Country, 2017-2027, Millions
    • Table 10: Asia-Pacific Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Table 11: Asia-Pacific Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 12: Asia-Pacific Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 13: Asia-Pacific Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 14: Asia-Pacific Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 15: China GDP Per Capita, 2017-2022, $
    • Table 16:  China Population, 2017-2027, Millions
    • Table 17: China Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Table 18: China Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 19: China Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 20: China Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 21: China Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 22: India Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Table 23: India Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 24: India Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 25: India Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 26: India Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 27: Japan Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Table 28: Japan Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 29: Japan Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 30: Japan Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 31: Japan Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 32: Australia Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Table 33: Australia Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 34: Australia Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 35: Australia Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 36: Australia Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 37: Indonesia Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Table 38: Indonesia Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 39: Indonesia Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 40: Indonesia Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 41: Indonesia Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 42: South Korea Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Table 43: South Korea Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 44: South Korea Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 45: South Korea Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 46: South Korea Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 47: Western Europe GDP Per Capita, By Country, 2017-2022, $
    • Table 48:  Western Europe Population, By Country, 2017-2027, Millions
    • Table 49: Western Europe Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Table 50: Western Europe Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 51: Western Europe Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 52: Western Europe Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 53: Western Europe Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 54: UK Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Table 55: UK Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 56: UK Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 57: UK Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 58: UK Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 59: Germany Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Table 60: Germany Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 61: Germany Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 62: Germany Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 63: Germany Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 64: France Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Table 65: France Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 66: France Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 67: France Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 68: France Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 69: Eastern Europe GDP Per Capita, By Country, 2017-2022, $
    • Table 70:  Eastern Europe Population, By Country, 2017-2027, Millions
    • Table 71: Eastern Europe Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Table 72: Eastern Europe Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 73: Eastern Europe Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 74: Eastern Europe Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 75: Eastern Europe Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 76: Russia Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Table 77: Russia Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 78: Russia Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 79: Russia Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 80: Russia Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 81: North America GDP Per Capita, By Country, 2017-2022, $
    • Table 82:  North America Population, By Country, 2017-2027, Millions
    • Table 83: North America Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Table 84: North America Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 85: North America Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 86: North America Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 87: North America Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 88: USA GDP Per Capita, 2017-2022, $
    • Table 89:  USA Population, 2017-2027, Millions
    • Table 90: USA Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Table 91: USA Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 92: USA Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 93: USA Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 94: USA Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 95: South America GDP Per Capita, By Country, 2017-2022, $
    • Table 96:  South America Population, By Country, 2017-2027, Millions
    • Table 97: South America Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Table 98: South America Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 99: South America Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 100: South America Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 101: South America Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 102: Brazil Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Table 103: Brazil Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 104: Brazil Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 105: Brazil Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 106: Brazil Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 107: Middle East GDP Per Capita, By Country, 2017-2022, $
    • Table 108:  Middle East Population, By Country, 2017-2027, Millions
    • Table 109: Middle East Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Table 110: Middle East Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 111: Middle East Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 112: Middle East Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 113: Middle East Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 114: Africa GDP Per Capita, By Country, 2017-2022, $
    • Table 115:  Africa Population, By Country, 2017-2027, Millions
    • Table 116: Africa Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Table 117: Africa Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 118: Africa Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 119: Africa Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 120: Africa Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 121: Global Pharmacogenomics Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)
    • Table 122: Illumina – Financial Performance, 2018– 2022, $ Billion
    • Table 123: Eurofins Scientific – Financial Overview, 2018 – 2022, $ Billion
    • Table 124: Myriad Genetics – Financial Performance, 2018 – 2022, $ Billion
    • Table 125: PerkinElmer – Financial Performance, 2018 – 2022, $ Billion
    • Table 126: Centogene – Financial Performance, 2018 – 2022, $ Million
    • Table 127: Global Pharmacogenomics Market Size Gain ($ Million), 2022 – 2027, By Country
    • Table 128: Global Pharmacogenomics Market Size Gain ($ Million), Segmentation By Technology, 2022 – 2027
    • Table 129: Global Pharmacogenomics Market Size Gain ($ Million), Segmentation By Application, 2022 – 2027
    • Table 130: Global Pharmacogenomics Market Size Gain ($ Million), Segmentation By End User, 2022 – 2027
    • Table 131: Pharmacogenomics - Market Data Sources

    List Of Figures

      Figure 1: Geographic Regions Covered
    • Figure 2: Global Pharmacogenomics Market Segmentation By Technology
    • Figure 3: Global Pharmacogenomics Market Segmentation By Application
    • Figure 4: Global Pharmacogenomics Market Segmentation By End User
    • Figure 5: Global Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Figure 6: Global Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 7: Global Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 8: Global Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 9: Global Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 10: Global Pharmacogenomics Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 11: Global Pharmacogenomics Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 12: Asia-Pacific Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Figure 13: Asia-Pacific Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 14: Asia-Pacific Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 15: Asia-Pacific Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 16: Asia-Pacific Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 17: China Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Figure 18: China Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 19: China Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 20: China Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 21: China Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 22: India Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Figure 23: India Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 24: India Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 25: India Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 26: India Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 27: Japan Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Figure 28: Japan Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 29: Japan Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 30: Japan Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 31: Japan Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 32: Australia Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Figure 33: Australia Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 34: Australia Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 35: Australia Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 36: Australia Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 37: Indonesia Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Figure 38: Indonesia Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 39: Indonesia Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 40: Indonesia Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 41: Indonesia Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 42: South Korea Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Figure 43: South Korea Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 44: South Korea Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 45: South Korea Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 46: South Korea Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 47: Western Europe Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Figure 48: Western Europe Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 49: Western Europe Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 50: Western Europe Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 51: Western Europe Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 52: UK Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Figure 53: UK Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 54: UK Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 55: UK Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 56: UK Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 57: Germany Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Figure 58: Germany Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 59: Germany Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 60: Germany Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 61: Germany Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 62: France Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Figure 63: France Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 64: France Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 65: France Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 66: France Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 67: Eastern Europe Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Figure 68: Eastern Europe Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 69: Eastern Europe Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 70: Eastern Europe Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 71: Eastern Europe Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 72: Russia Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Figure 73: Russia Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 74: Russia Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 75: Russia Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 76: Russia Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 77: North America Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Figure 78: North America Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 79: North America Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 80: North America Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 81: North America Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 82: USA Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Figure 83: USA Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 84: USA Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 85: USA Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 86: USA Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 87: South America Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Figure 88: South America Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 89: South America Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 90: South America Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 91: South America Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 92: Brazil Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Figure 93: Brazil Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 94: Brazil Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 95: Brazil Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 96: Brazil Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 97: Middle East Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Figure 98: Middle East Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 99: Middle East Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 100: Middle East Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 101: Middle East Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 102: Africa Pharmacogenomics Market, Historic, 2017 – 2022, $ Million
    • Figure 103: Africa Pharmacogenomics Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 104: Africa Pharmacogenomics Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 105: Africa Pharmacogenomics Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 106: Africa Pharmacogenomics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Figure 107: Global Pharmacogenomics Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)
    • Figure 108: Illumina – Financial Performance, 2018– 2022, $ Billion
    • Figure 109: Eurofins Scientific – Financial Overview, 2018 – 2022, $ Billion
    • Figure 110: Myriad Genetics – Financial Performance, 2018– 2022, $ Billion
    • Figure 111: PerkinElmer – Financial Performance, 2018– 2022, $ Billion
    • Figure 112: Centogene – Financial Performance, 2018– 2022, $ Million
    View Report
    View Report
    View Report
    View Report
    View Report
    View Report
    View Report
    View Report